Research ExplorerPublicationsAGO Algorithms for the Treatment of Breast Cancer: Update 20...

AGO Algorithms for the Treatment of Breast Cancer: Update 2021

Standard

AGO Algorithms for the Treatment of Breast Cancer: Update 2021. / Schneeweiss, Andreas; Fasching, Peter A; Fehm, Tanja; Gerber, Bernd; Jackisch, Christian; Loibl, Sibylle; Schmidt, Marcus; Stickeler, Elmar; Wöckel, Achim; Janni, Wolfgang; Müller, Volkmar; AGO Kommission Mamma .

In: GEBURTSH FRAUENHEILK, Vol. 81, No. 10, 10.2021, p. 1101-1111.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Schneeweiss, A, Fasching, PA, Fehm, T, Gerber, B, Jackisch, C, Loibl, S, Schmidt, M, Stickeler, E, Wöckel, A, Janni, W, Müller, V & AGO Kommission Mamma 2021, 'AGO Algorithms for the Treatment of Breast Cancer: Update 2021', GEBURTSH FRAUENHEILK, vol. 81, no. 10, pp. 1101-1111. https://doi.org/10.1055/a-1519-7089

APA

Schneeweiss, A., Fasching, P. A., Fehm, T., Gerber, B., Jackisch, C., Loibl, S., Schmidt, M., Stickeler, E., Wöckel, A., Janni, W., Müller, V., & AGO Kommission Mamma (2021). AGO Algorithms for the Treatment of Breast Cancer: Update 2021. GEBURTSH FRAUENHEILK, 81(10), 1101-1111. https://doi.org/10.1055/a-1519-7089

Vancouver

Schneeweiss A, Fasching PA, Fehm T, Gerber B, Jackisch C, Loibl S et al. AGO Algorithms for the Treatment of Breast Cancer: Update 2021. GEBURTSH FRAUENHEILK. 2021 Oct;81(10):1101-1111. https://doi.org/10.1055/a-1519-7089

Bibtex

@article{2426aa4bbcfc418c9cb8d25610ca8ac6,
title = "AGO Algorithms for the Treatment of Breast Cancer: Update 2021",
abstract = "Therapy options shown in the algorithms are based on the current AGO recommendations, but cannot represent all evidence-based treatment options, since prior therapies, performance status, comorbidities, patient preference, etc. must be taken into account for the actual treatment choice. In individual cases, other evidence-based treatment options may also be appropriate and justified. Regardless of approval status, the algorithms only take into account drugs that were available in Germany at the time the algorithm was last updated. Here we present the 2021 update of AGO treatment algorithms for early and metastatic breast cancer, which are intended to intensify structured treatment decision by providing reproducible and evidence-based treatment paths and may be helpful for a broad treatment landscape.",
author = "Andreas Schneeweiss and Fasching, {Peter A} and Tanja Fehm and Bernd Gerber and Christian Jackisch and Sibylle Loibl and Marcus Schmidt and Elmar Stickeler and Achim W{\"o}ckel and Wolfgang Janni and Volkmar M{\"u}ller and {AGO Kommission Mamma}",
note = "The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ).",
year = "2021",
month = oct,
doi = "10.1055/a-1519-7089",
language = "English",
volume = "81",
pages = "1101--1111",
journal = "GEBURTSH FRAUENHEILK",
issn = "0016-5751",
publisher = "Georg Thieme Verlag KG",
number = "10",

}

RIS

TY - JOUR

T1 - AGO Algorithms for the Treatment of Breast Cancer: Update 2021

AU - Schneeweiss, Andreas

AU - Fasching, Peter A

AU - Fehm, Tanja

AU - Gerber, Bernd

AU - Jackisch, Christian

AU - Loibl, Sibylle

AU - Schmidt, Marcus

AU - Stickeler, Elmar

AU - Wöckel, Achim

AU - Janni, Wolfgang

AU - Müller, Volkmar

AU - AGO Kommission Mamma

N1 - The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ).

PY - 2021/10

Y1 - 2021/10

N2 - Therapy options shown in the algorithms are based on the current AGO recommendations, but cannot represent all evidence-based treatment options, since prior therapies, performance status, comorbidities, patient preference, etc. must be taken into account for the actual treatment choice. In individual cases, other evidence-based treatment options may also be appropriate and justified. Regardless of approval status, the algorithms only take into account drugs that were available in Germany at the time the algorithm was last updated. Here we present the 2021 update of AGO treatment algorithms for early and metastatic breast cancer, which are intended to intensify structured treatment decision by providing reproducible and evidence-based treatment paths and may be helpful for a broad treatment landscape.

AB - Therapy options shown in the algorithms are based on the current AGO recommendations, but cannot represent all evidence-based treatment options, since prior therapies, performance status, comorbidities, patient preference, etc. must be taken into account for the actual treatment choice. In individual cases, other evidence-based treatment options may also be appropriate and justified. Regardless of approval status, the algorithms only take into account drugs that were available in Germany at the time the algorithm was last updated. Here we present the 2021 update of AGO treatment algorithms for early and metastatic breast cancer, which are intended to intensify structured treatment decision by providing reproducible and evidence-based treatment paths and may be helpful for a broad treatment landscape.

U2 - 10.1055/a-1519-7089

DO - 10.1055/a-1519-7089

M3 - SCORING: Journal article

C2 - 34629489

VL - 81

SP - 1101

EP - 1111

JO - GEBURTSH FRAUENHEILK

JF - GEBURTSH FRAUENHEILK

SN - 0016-5751

IS - 10

ER -